Handelsavisen
prelaunch
Companies ›Basic Materials ›ASH
AS
ASH — NYSE Diversified Chemicals

Ashland Inc.

$71,75
Open in Charts → Attach watcher ⌖
— —
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
3,300 USD
P/E
—
EV / Rev
0,6x
Div yield
2,41 %
Op margin
3,8 %
ROE
—
Net margin
—
Debt / equity
0,74
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
$72,70
Open
—
Next earnings
2026-11-09
Ex-dividend
—
TR 1Y
—
About

ASHLAND INC. is classified under Basic Materials / Commodity & Specialty Chemicals and appears not currently profitable on the latest normalized snapshot.

Business. Ashland Inc. (NYSE: ASH) is a global specialty chemicals company that develops and manufactures performance chemicals and materials. The firm operates within the commodity and specialty chemicals industry, focusing on product sales as its primary revenue model. Headquartered in the United States, Ashland is listed on the New York Stock Exchange under the ticker symbol ASH. Specific operating segments and geographic breakdowns are not provided in the available data.

Classification99 %
SectorBasic Materials
Industry groupDiversified Chemicals
Generated · rules-based
Sell-side consensus
BUY12 analysts
9 buy3 hold0 sell
Avg 12m price target76,75

Analyst recommendations

12 analysts · consensus Buy
Buy9
Hold3
Sell0
12-month price target
76,75
Consensus of sell-side coverage.
Upcoming events
  • EarningsFY 2026 earnings (expected)2026-11-09 · estimated
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Buy
12 analysts · indicative
Ownership→
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
largest disclosed fund holder
Profitability
—
not yet wired
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ASH.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ASH. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsFY 2026 earnings (expected)2026-11-09 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Ashland Inc. (NYSE: ASH) is a global specialty chemicals company that develops and manufactures performance chemicals and materials. The firm operates within the commodity and specialty chemicals industry, focusing on product sales as its primary revenue model. Headquartered in the United States, Ashland is listed on the New York Stock Exchange under the ticker symbol ASH. Specific operating segments and geographic breakdowns are not provided in the available data.

    Classification99 %
    SectorBasic Materials
    Industry groupDiversified Chemicals
    AI synthesis
    GENERATED

    ASHLAND INC. (ASH) is currently classified as Chemicals within Commodity & Specialty Chemicals (Basic Materials). Classification confidence: 0.70 (rule-based classification). Capital structure on the latest snapshot: total assets 4,499,000,000 USD, total equity 1,866,000,000, short-term debt 0, long-term debt 1,374,000,000. Net cash position is approximately -1,031,000,000 USD. Self-calculated market cap is 3,128 USD (market_price × shares_outstanding_diluted). Profitability profile: revenue 868,000,000, gross profit 252,000,000, operating income 33,000,000, net income 0. Risk profile from automated assessment: liquidity risk medium, dilution risk medium. Flags: Net cash is negative after subtracting total debt.; Source documents mention dilution or offering risk.. Recent news context: [TRIGGER] 8-K: 8-K (sec_8k_material) on ASH — filing_type=8-K; max_severity=high; ignored_items=['9.01']; material_items=['1.01', '2.03']; all_items_found=['1.01', '2.03', '9.01']; severity_per_code={'1.01': 'high', '2.03': 'medium'}; contributing_watchers=sec_8k_material (source=sec_8k_material; url=0001193125-26-328710). Additional context: 8-K: filing_type=8-K; max_severity=high; ignored_items=['9.01']; material_items=['1.01', '2.03']; all_items_found=['1.01', '2.03', '9.01']; severity_per_code={'1.01': 'high', '2.03': 'medium'}; contributing_watchers=sec_8k_material.

    Key takeaways
    • Debt to equity is about 0.74x.
    • [TRIGGER] 8-K: 8-K (sec_8k_material) on ASH — filing_type=8-K; max_severity=high; ignored_items=['9.01']; material_items=['1.01', '2.03']; all_items_found=['1.01', '2.03', '9.01']; severity_per_code={'1.01': 'high', '2.03': 'medium'}; contributing_watchers=sec_8k_material (source=sec_8k_material; url=0001193125-26-328710)
    • 10-Q Q2 0001674862 false --09-30 2026 http://fasb.org/us-gaap/2025#AccountsReceivableNetCurrent http://fasb.org/us-gaap/2025#AccountsReceivableNetCurrent http://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#AccountsReceivableNetCurrent http://fasb.org/us-gaap/2025#AccountsReceivableNetCurrent http://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#CostOfRevenue http://fasb.org/us-gaap/2025#CostOfRevenue http://fasb.org/us-gaap/2025#CostOfRevenue http://fasb.org/us-gaap/2025#CostOfRevenue http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2025#SellingGeneralAndAdministrativeExpense http://investor.ashland.com/20260331#ChairAndChiefExecutiveOfficerMember 0001674862 ash:TwoThousandTwentyFiveRestructuringProgramMember 2024-10-01 2025-03-31 0001674862 ash:IntermediatesMember srt:NorthAmericaMember 2025-10-01 2026-03-31 0001674862 us-gaap:CostOfSalesMember 2025-01-01 2025-03-31 0001674862 ash:PerformanceAdhesivesMember 2026-01-01 2026-03-31 0001674862 ash:SupplyChainFinanceProgramMember 2025-09-30 0001674862 us-gaap:RetainedEarningsMember 2025-09-30 0001674862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001674862 us-gaap:StockAppreciationRightsSARSMember 2025-01-01 2025-03-31 0001674862 ash:PersonalCareMember 2025-10-01 2026-03-31 0001674862 ash:LifeSciencesMember srt:AsiaPacificMember 2026-01-01 2026-03-31 0001674862 ash:SpecialtyAdditivesMember srt:EuropeMember 2025-01-01 2025-03-31 0001674862 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2026-03-31 0001674862 ash:AsbestosTrustMember 2025-09-30 0001674862 ash:SupplyChainFinanceProgramMember 2026-03-31 0001674862 ash:SpecialtyAdditivesMember 2025-10-01 2026-03-31 0001674862 us-gaap:AccountsReceivableMember us-gaap:CommodityContractMember 2026-03-31 0001674862 us-gaap:OperatingSegmentsMember ash:IntermediatesAndSolventsMember 2025-10-01 2026-03-31 0001674862 ash:USAccountsReceivableSalesProgramMember 2024-10-01 2025-03-31 0001674862 ash:SpecialtyAdditivesMember ash:LatinAmericaAndOtherMember 2025-10-01 2026-03-31 0001674862 ash:OperatingLeaseAssetsNetMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2024-10-01 2025-03-31 0001674862 ash:TwoThousandTwentyThreeRestructuringProgramMember 2025-01-01 2025-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember 2023-10-01 2024-09-30 0001674862 us-gaap:TrademarksAndTradeNamesMember 2026-01-01 2026-03-31 0001674862 ash:ValvolineIncMember 2026-01-01 2026-03-31 0001674862 us-gaap:ForeignExchangeContractMember us-gaap:AccountsReceivableMember 2025-12-31 0001674862 ash:UnallocatedAndOtherMember 2025-01-01 2025-03-31 0001674862 ash:TwoPointZeroZeroPercentageSeniorNotesDue2028Member 2025-09-30 0001674862 ash:TwoThousandTwentyFiveRestructuringProgramMember 2026-03-31 0001674862 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-09-30 0001674862 us-gaap:PerformanceSharesMember 2024-10-01 2025-03-31 0001674862 ash:EnvironmentalTrustMember 2025-09-30 0001674862 us-gaap:StockCompensationPlanMember 2025-01-01 2025-03-31 0001674862 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001674862 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ash:PolyvinylpyrrolidonesMember 2025-10-01 2026-03-31 0001674862 country:US 2026-03-31 0001674862 us-gaap:CommodityContractMember 2025-01-01 2025-03-31 0001674862 ash:LifeSciencesMember srt:EuropeMember 2026-01-01 2026-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember srt:MaximumMember 2026-01-01 2026-03-31 0001674862 ash:SpecialtyAdditivesMember srt:EuropeMember 2025-10-01 2026-03-31 0001674862 ash:PersonalCareMember srt:NorthAmericaMember 2025-01-01 2025-03-31 0001674862 ash:SpecialtyAdditivesMember srt:EuropeMember 2024-10-01 2025-03-31 0001674862 ash:LifeSciencesMember srt:NorthAmericaMember 2026-01-01 2026-03-31 0001674862 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2026-03-31 0001674862 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2026-01-01 2026-03-31 0001674862 ash:CellulosicsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2025-10-01 2026-03-31 0001674862 ash:TwoThousandTwentyThreeRestructuringProgramMember 2024-10-01 2025-03-31 0001674862 ash:WaterTechnologiesMember 2024-10-01 2025-03-31 0001674862 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001674862 us-gaap:FixedIncomeSecuritiesMember 2026-03-31 0001674862 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-10-01 2025-03-31 0001674862 ash:LifeSciencesMember ash:LatinAmericaAndOtherMember 2024-10-01 2025-03-31 0001674862 srt:MinimumMember 2026-01-01 2026-03-31 0001674862 us-gaap:StockCompensationPlanMember 2025-10-01 2026-03-31 0001674862 ash:LifeSciencesMember ash:RestructuringSeveranceCostsMember 2024-10-01 2025-03-31 0001674862 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2025-10-01 2026-03-31 0001674862 us-gaap:TrademarksAndTradeNamesMember 2025-09-30 0001674862 us-gaap:ForeignPlanMember 2026-03-31 0001674862 ash:SpecialtyAdditivesMember srt:NorthAmericaMember 2026-01-01 2026-03-31 0001674862 ash:PersonalCareMember srt:EuropeMember 2025-01-01 2025-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember srt:MaximumMember 2025-09-30 0001674862 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001674862 ash:IntermediatesMember srt:NorthAmericaMember 2024-10-01 2025-03-31 0001674862 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001674862 2025-03-31 0001674862 us-gaap:IntellectualPropertyMember srt:MaximumMember 2026-03-31 0001674862 us-gaap:CustomerListsMember 2026-03-31 0001674862 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001674862 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001674862 ash:CashSettledNonvestedRestrictedStockAwardsMember 2025-01-01 2025-03-31 0001674862 ash:IntermediatesMember 2025-01-01 2025-03-31 0001674862 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2025-01-01 2025-03-31 0001674862 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2025-09-30 0001674862 us-gaap:OtherCurrentLiabilitiesMember ash:AshlandGlobalHoldingsIncMember 2026-03-31 0001674862 us-gaap:RetainedEarningsMember 2025-12-31 0001674862 ash:TwoThousandTwentyFiveRestructuringProgramMember 2025-09-30 0001674862 ash:LifeSciencesMember us-gaap:OperatingSegmentsMember 2026-01-01 2026-03-31 0001674862 us-gaap:TradeAccountsReceivableMember 2025-09-30 0001674862 us-gaap:CorporateMember us-gaap:LandAndBuildingMember 2026-03-31 0001674862 ash:IntermediatesMember ash:LatinAmericaAndOtherMember 2025-01-01 2025-03-31 0001674862 ash:IntermediatesAndSolventsMember 2025-09-30 0001674862 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ash:PolyvinylpyrrolidonesMember 2025-01-01 2025-03-31 0001674862 us-gaap:StockAppreciationRightsSARSMember 2024-10-01 2025-03-31 0001674862 ash:SpecialtyAdditivesMember 2024-10-01 2025-03-31 0001674862 ash:TwoThousandTwentyFiveRestructuringProgramMember 2025-10-01 2026-03-31 0001674862 ash:USAccountsReceivableSalesProgramMember srt:MaximumMember 2026-03-31 0001674862 ash:LifeSciencesMember ash:RestructuringSeveranceCostsMember 2025-01-01 2025-03-31 0001674862 ash:CellulosicsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-10-01 2025-03-31 0001674862 ash:IntermediatesMember 2026-03-31 0001674862 ash:StockRepurchaseProgram2023Member 2025-01-01 2025-03-31 0001674862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-10-01 2026-03-31 0001674862 ash:HerculesLimitedLiabilityCompanyMember 2025-09-30 0001674862 2025-03-31 2025-03-31 0001674862 us-gaap:PensionPlansDefinedBenefitMember 2026-01-01 2026-03-31 0001674862 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2026-03-31 0001674862 us-gaap:OperatingSegmentsMember ash:PersonalCareAndHouseholdMember 2025-10-01 2026-03-31 0001674862 ash:SpecialtyAdditivesMember us-gaap:OperatingSegmentsMember 2026-01-01 2026-03-31 0001674862 us-gaap:TrademarksAndTradeNamesMember srt:MinimumMember 2026-03-31 0001674862 ash:SpecialtyAdditivesMember srt:AsiaPacificMember 2026-01-01 2026-03-31 0001674862 srt:MinimumMember 2024-10-01 2025-03-31 0001674862 us-gaap:CustomerListsMember 2025-09-30 0001674862 ash:AshlandGlobalHoldingsIncMember 2025-01-01 2025-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember 2024-09-30 0001674862 us-gaap:CorporateMember us-gaap:LandAndBuildingMember 2025-10-01 2026-03-31 0001674862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001674862 us-gaap:PerformanceSharesMember 2025-10-01 2026-03-31 0001674862 ash:IntermediatesMember ash:LatinAmericaAndOtherMember 2025-10-01 2026-03-31 0001674862 ash:AvocaMember 2025-10-01 2026-03-31 0001674862 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2025-10-01 2026-03-31 0001674862 ash:LifeSciencesMember 2024-10-01 2025-03-31 0001674862 us-gaap:IntersegmentEliminationMember 2024-10-01 2025-03-31 0001674862 ash:TwoThousandTwentyThreeRestructuringProgramMember 2026-01-01 2026-03-31 0001674862 ash:TwoPointZeroZeroPercentageSeniorNotesDue2028Member 2026-03-31 0001674862 ash:LifeSciencesMember srt:AsiaPacificMember 2025-01-01 2025-03-31 0001674862 ash:USAccountsReceivableSalesProgramMember 2025-01-01 2025-03-31 0001674862 ash:ForeignAccountsReceivableSalesProgramMember 2025-10-01 2026-03-31 0001674862 ash:PersonalCareMember srt:AsiaPacificMember 2025-01-01 2025-03-31 0001674862 ash:ThreePointThreeSevenFivePercentageSeniorNotesDue2031Member 2025-10-01 2026-03-31 0001674862 ash:HerculesLimitedLiabilityCompanyMember 2023-09-30 0001674862 ash:HerculesLimitedLiabilityCompanyMember 2024-09-30 0001674862 ash:HerculesLimitedLiabilityCompanyMember 2025-03-31 0001674862 srt:MinimumMember 2026-03-31 0001674862 ash:SpecialtyAdditivesMember srt:NorthAmericaMember 2024-10-01 2025-03-31 0001674862 ash:PerformanceAdhesivesMember 2024-10-01 2025-03-31 0001674862 ash:HerculesLimitedLiabilityCompanyMember 2026-03-31 0001674862 ash:ThreePointThreeSevenFivePercentageSeniorNotesDue2031Member 2024-10-01 2025-09-30 0001674862 us-gaap:GoodwillMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2024-10-01 2025-03-31 0001674862 us-gaap:PensionPlansDefinedBenefitMember 2025-10-01 2026-03-31 0001674862 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001674862 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2026-03-31 0001674862 us-gaap:CommodityContractMember 2026-01-01 2026-03-31 0001674862 ash:LifeSciencesMember srt:EuropeMember 2024-10-01 2025-03-31 0001674862 srt:MaximumMember us-gaap:CustomerListsMember 2026-03-31 0001674862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001674862 us-gaap:PropertyPlantAndEquipmentMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2024-10-01 2025-03-31 0001674862 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-09-30 0001674862 ash:UnallocatedAndOtherMember 2025-10-01 2026-03-31 0001674862 ash:UnallocatedAndOtherMember 2025-09-30 0001674862 ash:PersonalCareMember 2026-03-31 0001674862 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2025-09-30 0001674862 ash:SixPointEightSevenFivePercentageNotesDue2043Member 2026-03-31 0001674862 ash:IntermediatesMember 2025-10-01 2026-03-31 0001674862 ash:CellulosicsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2026-01-01 2026-03-31 0001674862 ash:PersonalCareMember 2026-01-01 2026-03-31 0001674862 ash:CashSettledNonvestedRestrictedStockAwardsMember 2024-10-01 2025-03-31 0001674862 us-gaap:IntersegmentEliminationMember 2026-01-01 2026-03-31 0001674862 ash:SpecialtyAdditivesMember srt:AsiaPacificMember 2025-01-01 2025-03-31 0001674862 ash:ValvolineIncMember 2025-10-01 2026-03-31 0001674862 ash:SpecialtyAdditivesMember 2025-01-01 2025-03-31 0001674862 ash:LifeSciencesMember 2026-01-01 2026-03-31 0001674862 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001674862 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-10-01 2025-03-31 0001674862 ash:LifeSciencesMember 2025-01-01 2025-03-31 0001674862 ash:IntermediatesMember srt:AsiaPacificMember 2024-10-01 2025-03-31 0001674862 ash:TwoThousandTwentyFiveRestructuringProgramMember 2025-01-01 2025-03-31 0001674862 ash:LifeSciencesMember 2025-09-30 0001674862 us-gaap:OtherCurrentLiabilitiesMember ash:AshlandGlobalHoldingsIncMember 2025-09-30 0001674862 ash:LifeSciencesMember srt:EuropeMember 2025-10-01 2026-03-31 0001674862 ash:LifeSciencesMember srt:EuropeMember 2025-01-01 2025-03-31 0001674862 us-gaap:AccountsReceivableMember us-gaap:ForeignExchangeContractMember 2025-09-30 0001674862 srt:MaximumMember 2026-03-31 0001674862 ash:TwoThousandTwentyThreeStockRepurchaseProgramMember 2023-06-28 0001674862 ash:TwoThousandTwentyFiveRestructuringProgramMember 2026-01-01 2026-03-31 0001674862 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001674862 us-gaap:RetainedEarningsMember 2024-10-01 2025-03-31 0001674862 ash:AvocaMember 2025-01-01 2025-03-31 0001674862 ash:SpecialtyAdditivesMember srt:AsiaPacificMember 2024-10-01 2025-03-31 0001674862 ash:USAccountsReceivableSalesProgramMember 2025-10-01 2026-03-31 0001674862 ash:ThreePointThreeSevenFivePercentageSeniorNotesDue2031Member 2025-09-30 0001674862 us-gaap:DiscontinuedOperationsHeldforsaleMember us-gaap:OtherCurrentAssetsMember 2024-10-01 2025-03-31 0001674862 ash:HerculesLimitedLiabilityCompanyMember us-gaap:AccountsReceivableMember 2025-09-30 0001674862 ash:SpecialtyAdditivesMember us-gaap:OperatingSegmentsMember 2025-01-01 2025-03-31 0001674862 ash:SpecialtyAdditivesMember ash:LatinAmericaAndOtherMember 2025-01-01 2025-03-31 0001674862 ash:LifeSciencesMember srt:AsiaPacificMember 2025-10-01 2026-03-31 0001674862 us-gaap:StockAppreciationRightsSARSMember 2026-01-01 2026-03-31 0001674862 ash:PriorFiscalYearMember 2024-10-01 2025-03-31 0001674862 us-gaap:CorporateMember us-gaap:LandAndBuildingMember 2025-01-01 2025-03-31 0001674862 us-gaap:StockCompensationPlanMember 2024-10-01 2025-03-31 0001674862 ash:LifeSciencesMember srt:NorthAmericaMember 2025-10-01 2026-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember 2025-10-01 2026-03-31 0001674862 ash:UnallocatedAndOtherMember 2026-01-01 2026-03-31 0001674862 ash:PersonalCareMember srt:EuropeMember 2025-10-01 2026-03-31 0001674862 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-12-31 0001674862 ash:CashSettledPerformanceSharesMember 2025-01-01 2025-03-31 0001674862 ash:LifeSciencesMember ash:LatinAmericaAndOtherMember 2026-01-01 2026-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember 2023-09-30 0001674862 us-gaap:CostOfSalesMember 2024-10-01 2025-03-31 0001674862 ash:PersonalCareAndHouseholdMember 2025-09-30 0001674862 us-gaap:OperatingSegmentsMember 2025-01-01 2025-03-31 0001674862 ash:ValvolineIncMember 2024-10-01 2025-03-31 0001674862 ash:SupplyChainFinanceProgramMember 2026-01-01 2026-03-31 0001674862 2025-10-01 2025-12-31 0001674862 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2025-09-30 0001674862 ash:ThreePointThreeSevenFivePercentageSeniorNotesDue2031Member 2026-03-31 0001674862 ash:IntermediatesMember ash:LatinAmericaAndOtherMember 2024-10-01 2025-03-31 0001674862 us-gaap:IntersegmentEliminationMember 2025-10-01 2026-03-31 0001674862 us-gaap:ForeignPlanMember 2025-10-01 2026-03-31 0001674862 ash:CashSettledPerformanceSharesMember srt:MaximumMember 2025-10-01 2026-03-31 0001674862 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ash:PolyvinylpyrrolidonesMember 2026-01-01 2026-03-31 0001674862 ash:PriorFiscalYearMember 2025-01-01 2025-03-31 0001674862 ash:TwoThousandTwentyThreeStockRepurchaseProgramMember 2026-03-31 0001674862 2025-10-01 2026-03-31 0001674862 ash:IntermediatesMember srt:AsiaPacificMember 2026-01-01 2026-03-31 0001674862 ash:SixPointFiveZeroPercentageJuniorSubordinatedNotesDue2029Member 2026-03-31 0001674862 ash:IntermediatesMember srt:AsiaPacificMember 2025-10-01 2026-03-31 0001674862 us-gaap:RetainedEarningsMember 2025-03-31 0001674862 ash:SpecialtyAdditivesMember 2026-03-31 0001674862 ash:IntermediatesAndSolventsMember 2026-03-31 0001674862 ash:SpecialtyAdditivesMember srt:NorthAmericaMember 2025-10-01 2026-03-31 0001674862 ash:LifeSciencesMember srt:NorthAmericaMember 2024-10-01 2025-03-31 0001674862 us-gaap:EquityFundsMember 2025-09-30 0001674862 ash:PersonalCareMember srt:NorthAmericaMember 2025-10-01 2026-03-31 0001674862 ash:SixPointEightSevenFivePercentageNotesDue2043Member 2024-10-01 2025-09-30 0001674862 ash:UnallocatedAndOtherMember 2024-10-01 2025-03-31 0001674862 us-gaap:OperatingSegmentsMember ash:IntermediatesAndSolventsMember 2026-01-01 2026-03-31 0001674862 ash:PersonalCareMember srt:EuropeMember 2024-10-01 2025-03-31 0001674862 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ash:CellulosicsAndPolyvinylpyrrolidonesMember 2024-10-01 2025-03-31 0001674862 ash:ValvolineIncMember 2025-01-01 2025-03-31 0001674862 us-gaap:OperatingSegmentsMember ash:IntermediatesAndSolventsMember 2024-10-01 2025-03-31 0001674862 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ash:PolyvinylpyrrolidonesMember 2024-10-01 2025-03-31 0001674862 us-gaap:CorporateMember us-gaap:LandAndBuildingMember 2024-10-01 2025-03-31 0001674862 ash:SpecialtyAdditivesMember ash:LatinAmericaAndOtherMember 2024-10-01 2025-03-31 0001674862 us-gaap:OperatingSegmentsMember ash:PersonalCareAndHouseholdMember 2024-10-01 2025-03-31 0001674862 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2025-12-31 0001674862 ash:PersonalCareMember 2024-10-01 2025-03-31 0001674862 us-gaap:CommodityContractMember 2025-10-01 2026-03-31 0001674862 us-gaap:CorporateMember us-gaap:LandAndBuildingMember 2025-03-31 0001674862 us-gaap:AccountsReceivableMember ash:AshlandGlobalHoldingsIncMember 2025-09-30 0001674862 ash:TwoThousandTwentyThreeRestructuringProgramMember 2025-10-01 2026-03-31 0001674862 srt:MinimumMember 2025-01-01 2025-03-31 0001674862 us-gaap:OperatingSegmentsMember 2026-01-01 2026-03-31 0001674862 us-gaap:CommodityContractMember 2024-10-01 2025-03-31 0001674862 2024-10-01 2025-03-31 0001674862 ash:SpecialtyAdditivesMember ash:LatinAmericaAndOtherMember 2026-01-01 2026-03-31 0001674862 ash:RestrictedSecuritiesMember 2025-09-30 0001674862 us-gaap:PerformanceSharesMember 2026-01-01 2026-03-31 0001674862 ash:CellulosicsMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2025-01-01 2025-03-31 0001674862 ash:IntermediatesMember 2026-01-01 2026-03-31 0001674862 ash:IntermediatesMember srt:EuropeMember 2026-01-01 2026-03-31 0001674862 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2025-09-30 0001674862 ash:SpecialtyAdditivesMember ash:RestructuringSeveranceCostsMember 2026-01-01 2026-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember 2025-09-30 0001674862 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-01-01 2025-03-31 0001674862 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ash:CellulosicsAndPolyvinylpyrrolidonesMember 2026-01-01 2026-03-31 0001674862 us-gaap:OperatingSegmentsMember ash:PersonalCareAndHouseholdMember 2026-01-01 2026-03-31 0001674862 ash:SupplyChainFinanceProgramMember 2025-10-01 2026-03-31 0001674862 us-gaap:TrademarksAndTradeNamesMember 2025-10-01 2026-03-31 0001674862 ash:IntermediatesMember srt:AsiaPacificMember 2025-01-01 2025-03-31 0001674862 ash:PerformanceAdhesivesMember 2025-01-01 2025-03-31 0001674862 ash:USAccountsReceivableSalesProgramMember srt:MaximumMember 2025-09-30 0001674862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001674862 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001674862 ash:EnvironmentalTrustMember 2026-03-31 0001674862 ash:TwoThousandTwentyThreeRestructuringProgramMember 2025-09-30 0001674862 us-gaap:IntellectualPropertyMember 2026-03-31 0001674862 us-gaap:StockCompensationPlanMember 2026-01-01 2026-03-31 0001674862 ash:USAccountsReceivableSalesProgramMember 2024-10-01 2025-09-30 0001674862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001674862 ash:SupplyChainFinanceProgramMember 2025-12-31 0001674862 ash:SixPointEightSevenFivePercentageNotesDue2043Member 2025-10-01 2026-03-31 0001674862 us-gaap:DemandDepositsMember 2026-03-31 0001674862 ash:IntermediatesMember ash:LatinAmericaAndOtherMember 2026-01-01 2026-03-31 0001674862 srt:MinimumMember 2025-10-01 2026-03-31 0001674862 ash:PersonalCareMember ash:LatinAmericaAndOtherMember 2026-01-01 2026-03-31 0001674862 ash:AvocaMember 2024-10-01 2025-03-31 0001674862 us-gaap:TrademarksAndTradeNamesMember srt:MaximumMember 2026-03-31 0001674862 ash:TwoPointZeroZeroPercentageSeniorNotesDue2028Member 2024-10-01 2025-09-30 0001674862 ash:IntermediatesMember srt:NorthAmericaMember 2026-01-01 2026-03-31 0001674862 us-gaap:CostOfSalesMember 2026-01-01 2026-03-31 0001674862 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2026-03-31 0001674862 country:US 2025-10-01 2026-03-31 0001674862 2025-01-01 2025-03-31 0001674862 ash:CashSettledPerformanceSharesMember 2026-01-01 2026-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember 2022-10-01 2023-09-30 0001674862 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember 2025-12-31 0001674862 ash:LifeSciencesMember 2025-10-01 2026-03-31 0001674862 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-09-30 0001674862 ash:PersonalCareMember srt:NorthAmericaMember 2024-10-01 2025-03-31 0001674862 us-gaap:OperatingSegmentsMember 2025-10-01 2026-03-31 0001674862 us-gaap:IntersegmentEliminationMember 2025-01-01 2025-03-31 0001674862 ash:HerculesLimitedLiabilityCompanyMember us-gaap:AccountsReceivableMember 2026-03-31 0001674862 ash:LifeSciencesMember us-gaap:OperatingSegmentsMember 2024-10-01 2025-03-31 0001674862 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2025-10-01 2026-03-31 0001674862 ash:IntermediatesMember srt:EuropeMember 2025-01-01 2025-03-31 0001674862 ash:IntermediatesMember srt:EuropeMember 2025-10-01 2026-03-31 0001674862 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2025-01-01 2025-03-31 0001674862 2025-09-30 0001674862 us-gaap:IntellectualPropertyMember srt:MinimumMember 2026-03-31 0001674862 ash:SpecialtyAdditivesMember 2025-09-30 0001674862 ash:CurrentFiscalYearMember 2025-10-01 2026-03-31 0001674862 ash:SpecialtyAdditivesMember srt:AsiaPacificMember 2025-10-01 2026-03-31 0001674862 ash:PersonalCareMember ash:LatinAmericaAndOtherMember 2025-10-01 2026-03-31 0001674862 ash:CashSettledNonvestedRestrictedStockAwardsMember 2026-01-01 2026-03-31 0001674862 ash:IntermediatesMember 2025-09-30 0001674862 ash:SpecialtyAdditivesMember us-gaap:OperatingSegmentsMember 2025-10-01 2026-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember 2024-10-01 2025-09-30 0001674862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001674862 us-gaap:RetainedEarningsMember 2025-10-01 2026-03-31 0001674862 us-gaap:StockAppreciationRightsSARSMember 2025-10-01 2026-03-31 0001674862 ash:PersonalCareMember 2025-09-30 0001674862 us-gaap:OtherLiabilitiesMember us-gaap:CommodityContractMember 2025-09-30 0001674862 us-gaap:PensionPlansDefinedBenefitMember 2025-01-01 2025-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember 2026-03-31 0001674862 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-10-01 2025-03-31 0001674862 ash:PersonalCareMember srt:AsiaPacificMember 2024-10-01 2025-03-31 0001674862 ash:LifeSciencesMember srt:AsiaPacificMember 2024-10-01 2025-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember 2025-03-31 0001674862 ash:PersonalCareMember ash:LatinAmericaAndOtherMember 2025-01-01 2025-03-31 0001674862 us-gaap:DemandDepositsMember 2025-09-30 0001674862 ash:LifeSciencesMember us-gaap:OperatingSegmentsMember 2025-10-01 2026-03-31 0001674862 us-gaap:FixedIncomeSecuritiesMember 2025-09-30 0001674862 ash:LifeSciencesMember 2026-03-31 0001674862 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2026-03-31 0001674862 2024-09-30 0001674862 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommodityContractMember 2025-09-30 0001674862 us-gaap:OperatingSegmentsMember ash:PersonalCareAndHouseholdMember 2025-01-01 2025-03-31 0001674862 us-gaap:OtherCurrentLiabilitiesMember ash:HerculesLimitedLiabilityCompanyMember 2025-09-30 0001674862 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001674862 ash:LifeSciencesMember us-gaap:OperatingSegmentsMember 2025-01-01 2025-03-31 0001674862 us-gaap:CostOfSalesMember 2025-10-01 2026-03-31 0001674862 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ash:CellulosicsAndPolyvinylpyrrolidonesMember 2025-01-01 2025-03-31 0001674862 ash:USAccountsReceivableSalesProgramMember srt:MaximumMember 2026-01-01 2026-03-31 0001674862 us-gaap:IntellectualPropertyMember 2025-09-30 0001674862 ash:ForeignAccountsReceivableSalesProgramMember 2024-10-01 2025-03-31 0001674862 ash:CurrentFiscalYearMember 2026-01-01 2026-03-31 0001674862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001674862 ash:StockRepurchaseProgram2023Member 2024-10-01 2025-03-31 0001674862 ash:PersonalCareMember srt:AsiaPacificMember 2025-10-01 2026-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember 2024-10-01 2025-03-31 0001674862 2024-10-01 2024-12-31 0001674862 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2026-01-01 2026-03-31 0001674862 ash:HerculesLimitedLiabilityCompanyMember 2024-10-01 2025-09-30 0001674862 ash:HerculesLimitedLiabilityCompanyMember 2022-10-01 2023-09-30 0001674862 ash:SixPointFiveZeroPercentageJuniorSubordinatedNotesDue2029Member 2025-10-01 2026-03-31 0001674862 ash:PersonalCareMember ash:LatinAmericaAndOtherMember 2024-10-01 2025-03-31 0001674862 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2026-01-01 2026-03-31 0001674862 ash:WaterTechnologiesMember 2026-01-01 2026-03-31 0001674862 us-gaap:OtherLiabilitiesMember us-gaap:CommodityContractMember 2026-03-31 0001674862 2026-03-31 0001674862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-01 2025-03-31 0001674862 us-gaap:TradeAccountsReceivableMember 2026-03-31 0001674862 ash:AsbestosTrustMember 2026-03-31 0001674862 us-gaap:PensionPlansDefinedBenefitMember 2024-10-01 2025-03-31 0001674862 ash:SpecialtyAdditivesMember 2026-01-01 2026-03-31 0001674862 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2025-03-31 0001674862 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember 2025-09-30 0001674862 us-gaap:OperatingSegmentsMember ash:IntermediatesAndSolventsMember 2025-01-01 2025-03-31 0001674862 ash:LifeSciencesMember srt:NorthAmericaMember 2025-01-01 2025-03-31 0001674862 srt:MinimumMember us-gaap:CustomerListsMember 2026-03-31 0001674862 ash:PersonalCareMember srt:EuropeMember 2026-01-01 2026-03-31 0001674862 us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2026-03-31 0001674862 us-gaap:DiscontinuedOperationsHeldforsaleMember 2025-01-01 2025-03-31 0001674862 ash:PersonalCareMember srt:AsiaPacificMember 2026-01-01 2026-03-31 0001674862 us-gaap:RetainedEarningsMember 2024-09-30 0001674862 us-gaap:RetainedEarningsMember 2026-03-31 0001674862 ash:SpecialtyAdditivesMember us-gaap:OperatingSegmentsMember 2024-10-01 2025-03-31 0001674862 us-gaap:EquityFundsMember 2026-03-31 0001674862 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-10-01 2026-03-31 0001674862 ash:TwoThousandTwentyThreeRestructuringProgramMember 2026-03-31 0001674862 ash:SpecialtyAdditivesMember srt:NorthAmericaMember 2025-01-01 2025-03-31 0001674862 us-gaap:OtherIntangibleAssetsMember us-gaap:DiscontinuedOperationsHeldforsaleMember 2024-10-01 2025-03-31 0001674862 ash:PersonalCareMember 2025-01-01 2025-03-31 0001674862 ash:CashSettledPerformanceSharesMember 2024-10-01 2025-03-31 0001674862 ash:IntermediatesMember srt:NorthAmericaMember 2025-01-01 2025-03-31 0001674862 us-gaap:DiscontinuedOperationsHeldforsaleMember 2024-10-01 2025-03-31 0001674862 us-gaap:AccountsReceivableMember ash:AshlandGlobalHoldingsIncMember 2026-03-31 0001674862 2026-01-01 2026-03-31 0001674862 us-gaap:TrademarksAndTradeNamesMember 2026-03-31 0001674862 ash:SixPointFiveZeroPercentageJuniorSubordinatedNotesDue2029Member 2024-10-01 2025-09-30 0001674862 ash:HerculesLimitedLiabilityCompanyMember 2025-10-01 2026-03-31 0001674862 ash:WaterTechnologiesMember 2025-01-01 2025-03-31 0001674862 ash:LifeSciencesMember ash:LatinAmericaAndOtherMember 2025-01-01 2025-03-31 0001674862 ash:CashSettledNonvestedRestrictedStockAwardsMember 2025-10-01 2026-03-31 0001674862 ash:PerformanceAdhesivesMember 2025-10-01 2026-03-31 0001674862 us-gaap:OtherCurrentLiabilitiesMember ash:HerculesLimitedLiabilityCompanyMember 2026-03-31 0001674862 ash:PersonalCareMember srt:NorthAmericaMember 2026-01-01 2026-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember 2022-09-30 0001674862 ash:SpecialtyAdditivesMember ash:RestructuringSeveranceCostsMember 2025-10-01 2026-03-31 0001674862 ash:IntermediatesMember 2024-10-01 2025-03-31 0001674862 us-gaap:PerformanceSharesMember 2025-01-01 2025-03-31 0001674862 ash:UnallocatedAndOtherMember 2026-03-31 0001674862 ash:WaterTechnologiesMember 2025-10-01 2026-03-31 0001674862 ash:HerculesLimitedLiabilityCompanyMember 2022-09-30 0001674862 us-gaap:AccountsReceivableMember us-gaap:CommodityContractMember 2025-09-30 0001674862 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001674862 us-gaap:RevolvingCreditFacilityMember 2026-03-31 0001674862 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2025-09-30 0001674862 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ash:CellulosicsAndPolyvinylpyrrolidonesMember 2025-10-01 2026-03-31 0001674862 ash:SixPointFiveZeroPercentageJuniorSubordinatedNotesDue2029Member 2025-09-30 0001674862 ash:LifeSciencesMember ash:LatinAmericaAndOtherMember 2025-10-01 2026-03-31 0001674862 ash:RestrictedSecuritiesMember 2026-03-31 0001674862 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-03-31 0001674862 us-gaap:RetainedEarningsMember 2024-12-31 0001674862 ash:HerculesLimitedLiabilityCompanyMember 2023-10-01 2024-09-30 0001674862 us-gaap:OperatingSegmentsMember 2024-10-01 2025-03-31 0001674862 ash:IntermediatesMember srt:EuropeMember 2024-10-01 2025-03-31 0001674862 ash:SixPointEightSevenFivePercentageNotesDue2043Member 2025-09-30 0001674862 ash:TwoPointZeroZeroPercentageSeniorNotesDue2028Member 2025-10-01 2026-03-31 0001674862 ash:SpecialtyAdditivesMember srt:EuropeMember 2026-01-01 2026-03-31 0001674862 ash:PersonalCareAndHouseholdMember 2026-03-31 0001674862 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember srt:MinimumMember 2025-10-01 2026-03-31 0001674862 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2024-10-01 2025-03-31 0001674862 ash:AshlandGlobalHoldingsIncMember srt:MaximumMember 2026-03-31 0001674862 ash:HerculesLimitedLiabilityCompanyMember 2024-10-01 2025-03-31 iso4217:EUR ash:Claim xbrli:pure iso4217:USD xbrli:shares ash:ReportableSegment ash:Site xbrli:shares ash:Employee ash:ServiceStationProperty ash:Facility iso4217:USD UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.
    • Ashland recorded an impairment charge of zero and $ 183 million ($ 1 million allocated to goodwill, $ 134 million to other intangible assets, $ 33 million to property, plant and equipment, $ 14 million to operating lease assets, net and $ 1 million to other current assets) within the income (loss) on divestitures, net caption of the Statement of Condensed Consolidated Comprehensive Income (Loss) for the three and six months ended March 31, 2025.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-03-31
    Q4 2025 · Quarter highlights

    Revenue $868.0M; Operating income $33.0M.

    Revenue$868.0M
    Operating income$33.0M
    Net income—
    Free cash flow—
    EPS—
    Operating cash flow—
    Financials
    Income statement
    Revenue$868.0M
    Gross profit$252.0M
    Operating income$33.0M
    Net income—
    Margins
    Gross margin29.0%
    Operating margin3.8%
    Net margin—
    FCF margin—
    Balance sheet
    Total assets$4.50B
    Total liabilities—
    Total equity$1.87B
    Cash & equivalents$343.0M
    Long-term debt$1.37B
    Cash flow
    Operating cash flow—
    CapEx$31.0M
    Free cash flow—
    SBC$9.0M
    P&L flow · revenue → net income
    Revenue $868.0MOperating costs $835.0M
    Highlights
    • ▍Revenue $868.0M
    • ▍Operating income $33.0M
    • ▍Operating margin 3.8%

    Valuation FY

    Market price
    $71,75
    Market cap
    $3.1k
    Enterprise valueⓘ
    $1.03B
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    0.6x
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    —
    Net cashⓘ
    -$1.03B
    Current ratioⓘ
    3.1
    Debt / equityⓘ
    0.7
    ROAⓘ
    —
    ROEⓘ
    —
    Cash conversionⓘ
    —
    CapEx / revenueⓘ
    3.6%
    SBC / revenueⓘ
    1.0%
    Dilution ratioⓘ
    —

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYBasic MaterialsIndustryDiversified Chemicals41,4B node revenueSSL 36,9%GRN 31,0%CC 14,0%HUN 13,7%ASH 4,4%AGIG 0,0%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)ASH 4,4% · rank #5 of 6

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    Peer comparison5 peers · vs ASH · multiples and returns
    SS
    SSL—
    Sasol Ltd
    —
    —
    P/E
    —
    — vs self
    Div yield
    —
    — vs self
    ROE
    —
    — vs self
    GR
    GRN—
    GRN.MI
    —
    —
    P/E
    —
    — vs self
    Div yield
    —
    — vs self
    ROE
    —
    — vs self
    CC
    CC—
    Chemours Co
    $17,11
    2,6B USD
    P/E
    —
    — vs self
    Div yield
    1,9 %
    -0,5 vs self
    ROE
    -179,5 %
    — vs self
    HU
    HUN—
    Huntsman Corp
    $11,43
    2,0B USD
    P/E
    —
    — vs self
    Div yield
    7,3 %
    +4,9 vs self
    ROE
    -10,6 %
    — vs self
    AG
    AGIG—
    Abundia Global Impact Group
    $0,95
    38,2M USD
    P/E
    —
    — vs self
    Div yield
    —
    — vs self
    ROE
    -83,3 %
    — vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 49 %
    EPS
    Consensus EPS
    3,60
    Predicted surprise
    +0,01
    Beat probability
    49 %
    Analysts
    12
    Other metrics
    Revenue
    —
    no estimate
    Segment revenue
    —
    no estimate
    Margin
    —
    no estimate
    Segment margin
    —
    no estimate
    as of 2026-06-25 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPS—no estimate—no estimate3,60
    Revenue—no estimate—no estimate1,8B USD
    Operating income—no estimate—no estimate210,0M USD
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution12 analysts
    Strong buy3
    Buy6
    Hold3
    Sell0
    Strong sell0
    12-month price target$68,85 · Median $68,00
    Low $50,00High $90,00
    Operating income · consensus210,0M USD
    EPS surprise
    −6,1 %
    reported vs consensus · miss
    Revenue surprise
    −1,3 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$58,00
    Mean$76,75
    Median$77,00
    High$90,00
    Spot$71,75
    +7.0 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskMedium
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.
    • Source documents mention dilution or offering risk.

    Benchmarks vs cohort

    Op Margin3,8 %Below median
    Capex / Rev3,6 %Best in class
    D/E0,74Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 308 687 sh5 exercises · 33 grants17 insiders
    • MUSA OSAMA MSVP and CTO · Stock Appreciation Rights → Common StockDisposed 9 793 @ $57,96exercise · 2026-07-29
    • Assis Alessandra FaccinSVP and GM, Life Sciences · Restricted Stock Unit → Common StockDisposed 3 215exercise · 2026-07-27
    • Bishop Steven DDirector · Common Stock Units → Common StockAcquired 379grant · 2026-06-30
    • Chattopadhyay SanatDirector · Common Stock Units → Common StockAcquired 218grant · 2026-06-30
    • LOY BERTRANDDirector · Restricted Stock Units → Common StockAcquired 1 741grant · 2026-05-15
    • MINICUCCI JAMES P.SVP and GM, Personal Care · Restricted Stock Unit → Common StockDisposed 4 310exercise · 2026-05-08
    • Bishop Steven DDirector · Common Stock Units → Common StockAcquired 450grant · 2026-03-31
    • Chattopadhyay SanatDirector · Common Stock Units → Common StockAcquired 258grant · 2026-03-31
    • NOVO GUILLERMODirector, Chair of the Board and CEO · Restricted Stock Units → Common StockAcquired 32 096grant · 2026-02-06
    • Kulkarni Ashish KDirector · Restricted Stock Units → Common StockAcquired 2 113exercise · 2026-01-21
    • Peribere Jerome ADirector · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • Chattopadhyay SanatDirector · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • Bishop Steven DDirector · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • Kulkarni Ashish KDirector · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • Harrison Suzan F.Director · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • Tozier ScottDirector · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • MAIN SUEDirector · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • Bishop Steven DDirector · Common Stock Units → Common StockAcquired 426grant · 2025-12-31
    • Chattopadhyay SanatDirector · Common Stock Units → Common StockAcquired 245grant · 2025-12-31
    • Caceres DagoSVP & GM, Specialty Additives · Restricted Stock Units → Common StockAcquired 4 250grant · 2025-11-19
    • Assis Alessandra FaccinSVP and GM, Life Sciences · Restricted Stock Units → Common StockAcquired 6 136grant · 2025-11-19
    • Assis Alessandra FaccinSVP and GM, Life Sciences · Stock Appreciation Rights → Common StockAcquired 13 807 @ $50,58grant · 2025-11-19
    • LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty. · Restricted Stock Units → Common StockAcquired 3 965grant · 2025-11-19
    • LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty. · Stock Appreciation Rights → Common StockAcquired 8 922 @ $50,58grant · 2025-11-19
    • NOVO GUILLERMODirector, Chair of the Board and CEO · Restricted Stock Units → Common StockAcquired 43 495grant · 2025-11-19

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Regulatory filings
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Ev To Operating Income
      enterprise_value / operating_income
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Ev To Revenue
      enterprise_value / revenue
    • Capex To Revenue
      capital_expenditure / revenue
    • Enterprise Value
      market_cap - net_cash
    Source documents
    • ASHLAND INC. company facts · 2026-08-01
    • ASHLAND INC. 10-Q 2026-04-29 · 2026-08-01
    • ASHLAND INC. 10-Q 2026-02-03 · 2026-08-01
    • ASHLAND INC. 10-K 2025-11-20 · 2026-08-01
    • ASHLAND INC. 10-Q 2025-07-30 · 2026-08-01
    • 8-K (sec_8k_material) on ASH · 2026-08-01
    • Ashland Inc Market data — analyst estimates · 2026-08-01
    • Ashland Inc Market data — ESG · 2026-08-01

    Ownership & reference

    Top holders

    • MASSACHUSETTS FINANCIAL SERVICES CO /MA/Institutional Investor · as of 2026-03-310,05 %$157M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,05 %$110M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,03 %$63M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,03 %$139M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,02 %$97M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,01 %$423M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,01 %$14M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,01 %$21M
    • EATON VANCE MANAGEMENTInstitutional Investor · as of 2022-09-300,01 %$0M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,00 %$9M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$266M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$24M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$27M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$17M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$86M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$47M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$15M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$7M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,00 %$3M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$7M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$10M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$7M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$10M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$18M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$3M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$3M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$1M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$0M

    Insider activity

    Mixed / flat0 buys · 0 sellsnet $05 insiders · last 365d
    • MUSA OSAMA MSVP and CTO · Common StockOther 1 267 @ $57,96$73K · 2026-07-29
    • Assis Alessandra FaccinSVP and GM, Life Sciences · Common StockOther 884 @ $66,38$59K · 2026-07-27
    • Assis Alessandra FaccinSVP and GM, Life Sciences · Common StockOther 3 215 @ $66,38$213K · 2026-07-27
    • MINICUCCI JAMES P.SVP and GM, Personal Care · Common StockOther 1 346 @ $55,01$74K · 2026-05-08
    • MINICUCCI JAMES P.SVP and GM, Personal Care · Common StockOther 4 310 @ $55,01$237K · 2026-05-08
    • Kulkarni Ashish KDirector · Common StockOther 2 113 · 2026-01-21
    • NOVO GUILLERMODirector, Chair of the Board and CEO · Common StockOther 6 122 @ $49,60$304K · 2025-11-17
    • NOVO GUILLERMODirector, Chair of the Board and CEO · Common StockOther 2 563 @ $49,60$127K · 2025-11-17

    Short positioning

    5.7Mshares short-0.7% vs prior
    9.72days to cover
    52.6%short of daily vol
    1.1Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ASHCanonical
    NYSE · USD

    Intel & risk

    PredictorBeat prob49 %Surprise+0,01Full forecast →
    What changed

    no material change vs prior analysis (walked 17 fields; 4 schema-expansion field(s) excluded)

    • Narrative— → —medium
    • Conclusion— → —medium
    • Key takeaways— → —medium
    • Company share pct— → —medium
    vs prior analysis 2 days ago
    peak dispatch · —
    OSINT findings
    Dilution riskMedium
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Source documents mention dilution or offering risk.

    Evidence & claims

    From filings & derived data
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -27.5%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 38.8%Derived (calculated)
    • Current ratio (FY 2025-12-31): 3.15xDerived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): -13.6%Derived (calculated)
    • Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 5.6%Derived (calculated)
    • Total assets (annual): USD 4.52BSEC XBRL filing
    • Shareholders' equity (annual): USD 1.88BSEC XBRL filing
    • Current assets (annual): USD 1.15BSEC XBRL filing
    • Current liabilities (annual): USD 366MSEC XBRL filing
    • Long-term debt (annual): USD 1.39BSEC XBRL filing
    • Cash & equivalents (annual): USD 304MSEC XBRL filing
    • Gross profit (YoY) (2025-09-30 vs 2024-09-30): -11.2%Derived (calculated)
    • Gross margin (FY 2025-09-30): 30.1%Derived (calculated)
    • Capex (YoY) (2025-09-30 vs 2024-09-30): -28.5%Derived (calculated)
    • Cost of revenue (YoY) (2025-09-30 vs 2024-09-30): -14.7%Derived (calculated)
    • EPS (basic) (YoY) (2025-09-30 vs 2024-09-30): -636.2%Derived (calculated)
    • EPS (diluted) (YoY) (2025-09-30 vs 2024-09-30): -642.6%Derived (calculated)
    • Operating income (YoY) (2025-09-30 vs 2024-09-30): -2,880.8%Derived (calculated)
    • R&D expense (YoY) (2025-09-30 vs 2024-09-30): -1.8%Derived (calculated)
    • Revenue (YoY) (2025-09-30 vs 2024-09-30): -13.7%Derived (calculated)
    • EPS (diluted) (annual): USD-PER-SHARES -18SEC XBRL filing
    • Cost of revenue (annual): USD 1.27BSEC XBRL filing
    • Pre-tax income (annual): USD -809MSEC XBRL filing
    • R&D expense (annual): USD 54MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-11-09EVENTUpcomingFY 2026 earnings (expected) estimated date
    2026-07-29EVENTQ3 2026 earnings (expected) estimated date
    2026-07-29INSIDERMUSA OSAMA M transacted 1.3k sh — SVP and CTO ~$73k
    2026-07-29INSIDERMUSA OSAMA M disposed of 9.8k sh Stock Appreciation Rights — SVP and CTO
    2026-07-28 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-28EVENTQ2 2026 earnings (expected) estimated date
    2026-07-27INSIDERAssis Alessandra Faccin transacted 3.2k sh — SVP and GM, Life Sciences ~$213k
    2026-07-27INSIDERAssis Alessandra Faccin transacted 884 sh — SVP and GM, Life Sciences ~$59k
    2026-07-27INSIDERAssis Alessandra Faccin disposed of 3.2k sh Restricted Stock Unit — SVP and GM, Life Sciences
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-30INSIDERBishop Steven D acquired 379 sh Common Stock Units — Director
    2026-06-30INSIDERChattopadhyay Sanat acquired 218 sh Common Stock Units — Director
    2026-05-29FILING8-K filing →
    2026-05-18FILING8-K filing →
    2026-05-15 00:00 UTCINSIDER4 insider transactions — 2026-05 · net buy $163k 2 derivative
    2026-05-15INSIDERLOY BERTRAND acquired 1.7k sh Restricted Stock Units — Director
    2026-05-08INSIDERMINICUCCI JAMES P. transacted 1.3k sh — SVP and GM, Personal Care ~$74k
    2026-05-08INSIDERMINICUCCI JAMES P. transacted 4.3k sh — SVP and GM, Personal Care ~$237k
    2026-05-08INSIDERMINICUCCI JAMES P. disposed of 4.3k sh Restricted Stock Unit — SVP and GM, Personal Care
    2026-04-29FILING10-Q filing →
    2026-04-28FILING8-K filing →
    2026-03-31 00:00 UTCINSIDER2 insider transactions — 2026-03 2 derivative
    2026-03-31EARNINGSQuarterly results — Q4 2025 Revenue USD 868.0M
    2026-03-31INSIDERChattopadhyay Sanat acquired 258 sh Common Stock Units — Director
    2026-03-31INSIDERBishop Steven D acquired 450 sh Common Stock Units — Director
    2026-02-06 00:00 UTCINSIDER1 insider transaction — 2026-02 1 derivative
    2026-02-06INSIDERNOVO GUILLERMO acquired 32.1k sh Restricted Stock Units — Director, Chair of the Board and CEO
    2026-02-03FILING10-Q filing →
    2026-02-02FILING8-K filing →
    2026-01-27FILING8-K filing →
    2026-01-22FILING8-K filing →
    2026-01-21 00:00 UTCINSIDER9 insider transactions — 2026-01 8 derivative
    2026-01-21INSIDERKulkarni Ashish K transacted 2.1k sh — Director
    2026-01-21INSIDERKulkarni Ashish K acquired 2.1k sh Restricted Stock Units — Director
    2026-01-20INSIDERBishop Steven D acquired 2.4k sh Restricted Stock Units — Director
    2026-01-20INSIDERKulkarni Ashish K acquired 2.4k sh Restricted Stock Units — Director
    2026-01-20INSIDERMAIN SUE acquired 2.4k sh Restricted Stock Units — Director
    2026-01-20INSIDERChattopadhyay Sanat acquired 2.4k sh Restricted Stock Units — Director
    2026-01-20INSIDERHarrison Suzan F. acquired 2.4k sh Restricted Stock Units — Director
    2026-01-20INSIDERTozier Scott acquired 2.4k sh Restricted Stock Units — Director
    Showing the 40 most recent of 63 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage